Cambridge Investment Research Advisors, Inc. - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 46 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q3 2017$28,000
-46.2%
19,3410.0%0.00%
-100.0%
Q2 2017$52,000
-33.3%
19,3410.0%0.00%0.0%
Q1 2017$78,000
-3.7%
19,3410.0%0.00%
-50.0%
Q4 2016$81,000
-38.6%
19,3410.0%0.00%0.0%
Q3 2016$132,000
+85.9%
19,341
+57.4%
0.00%0.0%
Q2 2016$71,000
-2.7%
12,291
+17.1%
0.00%0.0%
Q1 2016$73,000
-3.9%
10,5000.0%0.00%0.0%
Q4 2015$76,000
-16.5%
10,5000.0%0.00%
-33.3%
Q3 2015$91,00010,5000.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2017
NameSharesValueWeighting ↓
IMS Capital Management 624,673$481,0000.30%
WEDBUSH SECURITIES INC 98,255$76,0000.01%
Paulson Wealth Management Inc. 11,250$9,0000.01%
Indiana Trust & Investment Management CO 19,250$15,0000.01%
HYMAN CHARLES D 30,000$23,0000.00%
Baker Brothers Advisors 331,393$255,0000.00%
Virtu Financial LLC 41,079$32,0000.00%
WELCH & FORBES LLC 100,393$78,0000.00%
BOSTON FINANCIAL MANGEMENT LLC 42,424$33,0000.00%
Valeo Financial Advisors, LLC 5,750$4,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders